NALE(TM) Monoclonal Antibody to TLR9 (Clone: ABM1C51)

Produktübersicht

• Artikelname: NALE(TM) Monoclonal Antibody to TLR9 (Clone: ABM1C51)
• Artikelnummer: ABI-10-3003-NALE
• Hersteller Artikelnummer: 10-3003-NALE
• Alternativnummer: ABI-10-3003-NALE-100UG
• Hersteller: Abeomics
• Wirt: Mouse
• Kategorie: Antikörper
• Applikation: FACS, IHC, WB
• Spezies Reaktivität: Human, Mouse
• Immunogen: A partial length recombinant TLR9 protein (amino acids 100-290) was used as the immunogen for the antibody.
• Alternative Synonym: TLR9||UNQ5798/PRO19605

Produktbeschreibung

TLR9, a member of toll-like receptor family are central to the innate immunity by identifying pathogen associated molecular patterns (PAMPs). TLR9 identify unmethylated CpG dinucleotides present in bacterial DNA leading to NF-kB activation.

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [ABM1C51]
• NCBI: 54106
• UniProt: Q9NR96
• Reinheit: Protein G Chromatography
• Formulierung: Azide Free,Purified
• Target-Kategorie: TLR9

Anwendungsbeschreibung

• Application Verdünnung: Western blot analysis: 2-4 µg/ml, FACS analysis: 0.5 µg/10 6 cells, Immunohistochemical analysis: 5 µg/ml

Bilder

Fig-3: Intracellular flow analysis of TLR9 in human PBMC (Lymphocytes) using 0.5 µg/10 6 cells of TLR9 antibody (Clone: ABM1C51). Green represents isotype control, red represents anti-TLR9 antibody. Goat anti-mouse PE conjugate was used as secondary.

Fig-5 : Immunohistochemical analysis of TLR9 in human Liver tissue using TLR9 antibody (Clone: ABM1C51) at 20 µg/ml.

Fig-1: Immunohistochemical analysis of TLR9 in human stomach tissue using TLR9 antibody (Clone: ABM1C51) at 5 µg/ml.

Fig-2: Western blot analysis of TLR9. Anti- TLR9 antibody (Clone: ABM1C51) was used at 2 µg/ml on (1) Raji and (2) EL4 lysates.

Fig-4: Intracellular flow analysis of TLR9 in Raji cells using 0.5 µg/10 6 cells of TLR9 antibody (Clone: ABM1C51). Green represents isotype control, red represents anti-TLR9 antibody. Goat anti-mouse PE conjugate was used as secondary antibody.